Prognostic Factors for Regorafenib Treatment in Patients With Refractory Metastatic Colorectal Cancer: A Real-Life Retrospective Multi-Center Study. Biomol Biomed 2023, 23 (6), 1089–1095. https://doi.org/10.17305/bb.2023.9253.